In Reply Decision making on the use of oral anticoagulant treatment in patients with atrial fibrillation is often uncomplicated due to the positive risk-benefit ratio, ie, balancing risk of bleeding against benefit from thromboprophylaxis. Observational data on patients with atrial fibrillation sustaining an intracranial hemorrhage are increasing, recognizing the treatment conundrum of resuming oral anticoagulant treatment since the risk-benefit ratio of treatment is shifted substantially.
Nielsen PB, Larsen TB, Lip GYH. All Types of Hemorrhagic Stroke Are Not Created Equally—Reply. JAMA Intern Med. 2017;177(9):1399. doi:10.1001/jamainternmed.2017.3240
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.